Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 2:12:355-365.
doi: 10.2147/CEG.S192563. eCollection 2019.

The burden of irritable bowel syndrome and chronic constipation on health-related quality of life in black Africans: a comparison with healthy control subjects in Côte d'Ivoire, West Africa

Affiliations

The burden of irritable bowel syndrome and chronic constipation on health-related quality of life in black Africans: a comparison with healthy control subjects in Côte d'Ivoire, West Africa

Alassan Kouamé Mahassadi et al. Clin Exp Gastroenterol. .

Abstract

Background: Although patients with irritable bowel syndrome (IBS) and chronic constipation (CC) have an impaired health-related quality of life (HRQoL), little is known in black African patients compared with control subjects. This study provided the magnitude and the influencing factors of HRQoL impairment in black African outpatients with IBS or CC compared with control subjects using the generic SF-36 questionnaire. Materials and methods: One hundred and four consecutive black African outpatients complaining with IBS (n=72, mean age=38.9 years, female=62.5%) and CC (n=32, mean age=37.4 years, female=75%) met Rome 3 criteria were compared with 210 control subjects (mean age=37.4 years, 63.8% male). The SF-36 scores in all domains of HRQoL with the corresponding physical (PCS) and mental (MCS) composite scores between groups were compared with post hoc analysis and multivariate linear regression analysis for the assessment of the influencing factors. Results: Overall, IBS and CC patients exhibited low SF-36 scores in the 8 domains of HRQoL in comparison with control subjects. IBS patients scored less in mental health (mean difference=-10.3, p=0.001), bodily pain (mean difference=-23.5, p≤0.0001), and social functioning domains (mean difference =-15.1, p=0.01) in comparison with CC patients. Post hoc analysis demonstrated a trend down of PCS (mean difference=-12.9, p<0.0001) and MCS (mean difference=-11.2, p=0.01) disfavoring IBS patients than those with CC in comparison with control subjects. In multivariate linear regression analysis, besides the negative impact of IBS and CC, factors influencing PCS were BMI (β=0.4; p=0.01) and comorbidities (β=-5.9; p=0.002). Those influencing MCS were the presence of remunerated activity (β=2.7, p=0.02), and patient living alone (β=9.4; p=0.04). Conclusion: IBS and CC impact negatively on the HRQoL in black African subjects and more importantly in those with IBS than CC.

Keywords: SF-36 questionnaire; black Africans; chronic constipation; irritable bowel syndrome; quality of life.

PubMed Disclaimer

Conflict of interest statement

Dr Alassan Kouamé Mahassadi reports personal fees and non-financial support from Genix Pharma and Sanofi, outside the submitted work. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Distribution and trend of means scores of SF-36questionnaire items adjusted to age within all subgroups. Lines were smoothed because of the presence of one subject in the belonging age class. Abbreviations: IBS, irritable bowel syndrome; CC, chronic constipation; Ct, controls; PF, physical functioning; RP, role of physical; RE, role of emotional; BP, bodily pain; SF, social functioning; GH, general health; VT, vitality; MH, mental health; PCS, physical composite score; MCS, mental composite score.
Figure 2
Figure 2
Box plots depicting the distribution and trends of physical (A) and mental (B) composite scores between patients with irritable bowel syndrome, chronic constipation, and control subjects. The box represents the interquartile range; the top and the bottom of the box are, respectively, the 25th and 75th percentile. The line across the box is the median. The lower and upper values are indicated by the whiskers. Stars and circles represent the outliers and extreme values. Abbreviations: IBS, irritable bowel syndrome; CC, chronic constipation.
Figure 3
Figure 3
Box plots depicting the distribution, comparison, and trends of physical (A) and mental (B) composite summaries between subjects with no painful chronic constipation (0), painful chronic constipation (1) and irritable bowel syndrome (2). The box represents the interquartile range; the top and the bottom of the box are, respectively, the 25th and 75th percentile. The line across the box is the median. The lower and upper values are indicated by the whiskers. Stars and circles represent outliers and extreme values. SE: standard error, Q = calculated statistic, Q(0.05): the critical value of tabled Q statistic =2.39. KW = Kruskal Wallis test. Abbreviations: IBS, irritable bowel syndrome; CC, chronic constipation.

References

    1. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712–721.e4. doi:10.1016/j.cgh.2012.02.029 - DOI - PubMed
    1. Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011;106:1582–1591. doi:10.1038/ajg.2011.164 - DOI - PubMed
    1. Longstreth GF, Grant Thompson W, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterol. 2006;130:1480–1491. doi:10.1053/j.gastro.2005.11.061 - DOI - PubMed
    1. Gralnek JM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterol. 2000;119:654–660. doi:10.1053/gast.2000.16484 - DOI - PubMed
    1. Wald A, Scarpignato C, Kamm AM, et al. The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther. 2007;26:227–236. doi:10.1111/j.1365-2036.2007.03376.x - DOI - PubMed